Cancer Prevention Pharmaceuticals Competitors and Similar CompaniesClear all
Cancer Prevention Pharmaceuticals's competitors and similar companies include APEIRON Biologics, Molecular Templates, ARIAD Pharmaceuticals and AIM ImmunoTech.
 Cancer Prevention Pharmaceuticals Cancer Prevention Pharmaceuticals is a company developing therapeutics designed to reduce the risk of cancer and other diseases. |  APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  AIM ImmunoTech AIM ImmunoTech (formerly known as Hemispherx Biopharma) is an immuno-tech company focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases. | |
Founding Date | Founding Date 2008 | Founding Date 2005 | Founding Date 2009 | Founding Date 1991 | Founding Date 1990 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Wien, AT HQ | Locations Austin, US HQ New York, US | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Ocala, US HQ New Brunswick, US |
Employees | Employees 5 | Employees 5 | Employees 6272% decrease | Employees 1381% increase | Employees 3124% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.3 m | Valuation ($) N/A | Valuation ($) 17.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $57.3m (FY, 2023) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $88k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.1m (FY, 2015) | Cost of goods $128k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $116.7m (FY, 2015) | Gross profit ($40k) (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($8.1m) (FY, 2023) | Net income ($231.2m) (FY, 2015) | Net income ($14m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 9.3m | Total funding raised N/A | Total funding raised $ 89.6m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
APEIRON Biologics
HQ
Wien, AT
Employees
5
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View companyMolecular Templates
HQ
Austin, US
Employees
62
Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.
View companyARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View companyAIM ImmunoTech
HQ
Ocala, US
Employees
31↑ 24% increase
AIM ImmunoTech (formerly known as Hemispherx Biopharma) is an immuno-tech company focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases.
View company